scholarly journals Treatment of Glaucoma Patients with Flammer Syndrome

2021 ◽  
Vol 10 (18) ◽  
pp. 4227
Author(s):  
Katarzyna Konieczka ◽  
Josef Flammer

Flammer syndrome (FS) describes a phenotype characterized by the presence of primary vascular dysregulation along with a number of symptoms and signs. Although most people with FS are healthy, FS favors the occurrence of certain diseases, such as normal tension glaucoma. This is because disturbed autoregulation makes the eye more sensitive to intraocular pressure (IOP) spikes or blood pressure drops. Treatment of FS is generally appropriate when patients either suffer greatly from their symptoms or if we can assume that it has contributed to a disease. In glaucoma, this may be the case if the glaucoma damage progresses despite well-controlled IOP. Both the still sparse scientific studies and our long clinical experience suggest that FS-targeted therapy not only relieves the symptoms of FS but also slows the progression of glaucoma damage in selected cases. This description is intended not only to help affected patients but to also motivate clinicians and researchers to conduct therapy studies to confirm or refute our observations.

2020 ◽  
Author(s):  
Zakieh Vahedian ◽  
Maneli Mozaffarieh

The need of blood flow to different organs varies rapidly over time which is why there is a need for sophisticated local regulation of blood flow. The term “dysregulation” just simply means that blood flow is not properly adapted to this need. Dysregulative mechanisms can therefore lead to an over- or under-perfusion. A constant over- or under-perfusion does not normally induce long-term damage. A repeated under-perfusion, such as a repeated mild reperfusion injury, however, leads to damage. Systemic dysregulation can be primary or secondary of nature. A secondary dysregulation (SVD) is due to other diseases such as autoimmune diseases. The term Flammer Syndrome (FS) named after the famous physician J. Flammer refers to a clinical entity comprising a complex of clinical features caused mainly by dysregulation of the blood supply which has previously been called primary vascular dysregulation. People with FS tend to have cold extremities, prolonged sleep-onset time, altered drug sensitivity, low blood pressure and higher smell score, and increased retinal venous pressures as measured by means of ophthalmodynamometry. In the eye, the spatial irregularity of the retinal arteries is increased, and optic nerve head blood flow is correlated with finger blood flow indirectly indicating that the local regulation is disturbed. Blood flow is, on average, reduced in glaucoma patients, particularly in patients with normal-tension glaucoma suffering from FS, and in patients with high-tension glaucoma, which progress despite a normalized intraocular pressure (IOP). A constant reduction of blood flow (as we see in SVD) can lead to atrophy but does not contribute to glaucomatous atrophy. An increased variation of microcirculation as commonly seen in glaucoma patients with FS, however, is clearly linked to occurrence and progression of glaucomatous optic neuropathy (GON). Oxygen supply to the eye fluctuates, either if IOP fluctuates on a high level or blood pressure on a low level or if autoregulation is disturbed. Autoregulation is disturbed in patients with primary vascular dysregulation (PVD). Unstable oxygen supply to the optic nerve head leads to oxidative stress, which in turn, leads to the production of peroxynitrite (ONOO-) which finally kills the cells. In this review, we are talking about pathogenesis of the FS and some suggested therapeutic options for it.


2015 ◽  
Vol 2015 ◽  
pp. 1-12 ◽  
Author(s):  
Dominika Wróbel-Dudzińska ◽  
Ewa Kosior-Jarecka ◽  
Urszula Łukasik ◽  
Janusz Kocki ◽  
Agnieszka Witczak ◽  
...  

The aimof the research is to analyse the influence of polymorphisms of endothelin-1 gene and endothelin-1 receptor type A gene on the clinical condition of patients with primary open angle glaucoma.Methods. 285 Polish patients took part in the research (160 normal-tension glaucoma and 125 high-tension glaucoma). DNA was isolated by standard methods and genotype distributions of four polymorphisms in genes encoding endothelin-1 (K198N) and endothelin-1 receptor type A polymorphisms (C1222T, C70G, and G231A) were determined. Genotype distributions were compared between NTG and HTG groups. The clinical condition of participants was examined for association with polymorphisms.Results. A similar frequency of occurrence of the polymorphic varieties of the studied genes was observed in patients with NTG and HTG. There is no relation between NTG risk factors and examined polymorphisms. NTG patients with TT genotype of K198N polymorphism presented with the lowest intraocular pressure in comparison to GG + GT genotype (p=0.03). In NTG patients with CC genotype of C1222T polymorphism (p=0.028) and GG of C70G polymorphism (p=0.03) the lowest values of mean blood pressure were observed.Conclusions. The studied polymorphic varieties (K198N, C1222T) do have an influence on intraocular pressure as well as arterial blood pressure in NTG patients.


2014 ◽  
Vol 231 (04) ◽  
pp. 344-347 ◽  
Author(s):  
K. Konieczka ◽  
H. Choi ◽  
S. Koch ◽  
A. Schoetzau ◽  
D. Küenzi ◽  
...  

2016 ◽  
Vol 7 (1) ◽  
Author(s):  
Katarzyna Konieczka ◽  
Simone Koch ◽  
Tatjana Binggeli ◽  
Andreas Schoetzau ◽  
Juerg Kesselring

2008 ◽  
Vol 92 (9) ◽  
pp. 1227-1231 ◽  
Author(s):  
L Quaranta ◽  
T Pizzolante ◽  
I Riva ◽  
A-B Haidich ◽  
A G P Konstas ◽  
...  

2020 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Boo Hui Tan ◽  
Alexandra Young ◽  
Eleonora Bianchi ◽  
Lyndsay Brown ◽  
Andrew J. Tatham

Sign in / Sign up

Export Citation Format

Share Document